Insulin Pumps Market to Witness Increased Incremental Dollar Opportunity during the Forecast Period 2019-2026 | Animus Corporation, Asante, Insulet Corporation, Nipro Diagnostic, Cellnovo Ltd., Ypsomed Group

The global Insulin Pumps Market is expected to reach USD 9.41 Billion by 2027, according to a new report by Reports and Data. Insulin pumps are used for insulin therapy and is used for the treatment of patients with all types of diabetes.

The need for insulin therapy depends upon the balance between insulin resistance and insulin secretion. Patients with type 1 diabetes require insulin treatment permanently unless they receive a whole organ pancreas transplant or an islet. Type 2 diabetes patients require insulin as their beta-cell function lowers over time.

We provide you a thoroughly inspected Competitive Analysis against the global landscape by looking at our Sample Report@ https://www.reportsanddata.com/sample-enquiry-form/2346

Key participants include Animus Corporation, Asante, Insulet Corporation, Nipro Diagnostic Inc., Cellnovo Ltd., Ypsomed Group, Medtronics Inc., Tandem Diabetes Care Inc., Roche, and Valeritas, among others.

Diabetes and its complications, societal costs, and deaths have a huge and rapidly growing impact across the globe. In 2019: approximate 463 million adults (20-79 years) were living with diabetes, and by 2045, this is expected to rise to 700 million. A growing number of diabetic patients are propelling the demand for insulin.

Technological advancements in the insulin pumps have led to improved reliability and functionality. CSII (continuous subcutaneous insulin infusion) technology has observed several advancements, comprising the incorporation of continuous glucose monitoring (CGM) with the insulin pump. At present, these pumps with the integration of AI are capable of controlling the algorithm that analyzes the blood glucose level and automatically delivers the insulin to the individual using it.

The market in Asia Pacific is estimated to witness an increasing demand in the forecast period owing to growing awareness pertaining to medical treatments and care, rising health care sector, and an increase in R&D activities. Further, a rapid increase in the diabetic population and increasing adoption of insulin administration are driving the market demand in the region.

For the purpose of this report, Reports and Data have segmented the global insulin pumps market on the basis of product type, accessories, end-user, and region:

Product Type Outlook (Revenue, USD Million; 2016-2027)
o Traditional Insulin Pump
o Disposable Insulin Pump

Accessories Outlook (Revenue, USD Million; 2016-2027)
o Insulin Set Insertion Devices
o Insulin Cartridges
o Battery

End-User Outlook (Revenue, USD Million; 2016-2027)
o Hospitals & Clinics
o Laboratories
o Homecare settings

Purchase the complete report at discounts like never before, visit @ https://www.reportsanddata.com/discount-enquiry-form/2346

Regional Outlook (Revenue, USD Million; 2016-2027)
o North America (United States, Canada and Mexico)
o Europe (Germany, France, UK, Russia and Italy)
o Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
o South America (Brazil, Argentina, Colombia)

Further key findings from the report suggest
o By product, traditional insulin pumps dominated the market share in 2018 and is likely to experience a growth rate of 8.9% in the forecast period. The growth of these type of pumps is primarily owing to their better reliability and high availability of the product.
o By accessories, the insulin set insertion device held the largest market share in 2018 and is estimated to witness a growth rate of 9.2% in the forecast period. The market dominance of this insulin pump accessory is attributed to its high usage frequency.
o By end-users, hospitals & clinics dominated the market in 2018 and are projected to have a CAGR of 9.0% in the forecast period. The market dominance is owing to the higher acceptance of advanced technologies, well-established healthcare facilities, increasing government funding, and rising private sector investments in the healthcare sector.
o North America dominated the market in 2018 and is anticipated to grow at a rate of 8.9% in the period 2019-2027. Rapid technological advancements, increasing prevalence of diabetes, and new product launches by market players, among others, are causative of the high market demand in the region.

Major selling points of this research report
1. Gives the reader a holistic comprehension of the global market
2. Identifies the recent trends and estimated growth rate for the forecast duration
3. Helps industry experts, investors, and other participants implement lucrative expansion approaches
4. Provides accurate market insights to take informed decisions through presentations and other tools
5. Outlines the competitive landscapes with the individual market share of top vendors

To get the full report on the Insulin Pumps Market, with global and region-wise coverage, visit this link now@ https://www.reportsanddata.com/report-detail/insulin-pumps-market

Thanks for reading this article; you can also customize this report to get select chapters or region-wise coverage with regions like Asia, United States, Europe, etc.

Contact Us:

John Watson
Head of Business Development
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industry including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.